Kira Pharmaceuticals

R&D company focused on manufacturing of drugs for multiple therapeutic areas

placeHong Kong, Hong Kong, China calendar_todayFounded 2017 groups39 employees language kirapharma.com

Investor mix

10 investors on record; lead investors include RA Capital Management, Vivo Capital, Quan Capital, Qiming Venture Partners.

Investor typeCountShare
Venture capital550%
Private equity330%
Other / undisclosed220%
Coming soon